Form 4: Integra LifeSciences EVP & CHRO Reports Stock Disposal
SEC Form 4 Filing
Chantal Veillon-Berteloot, EVP & CHRO of Integra LifeSciences, reports disposing of 1,412 shares of common stock on September 1, 2024, to cover tax obligations.
Summary
- On September 1, 2024, Chantal Veillon-Berteloot, the EVP & CHRO of Integra LifeSciences Holdings Corp, disposed of 1,412 shares of common stock.
- The transaction was executed at a price of $20.34 per share.
- Following the transaction, Veillon-Berteloot directly owns 24,379 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock disposal by a company executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a disposal of shares by an executive, which could be for various reasons, including tax obligations or portfolio diversification.
Stakeholder Impact
- The disposal of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction, but is unlikely to have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 09/01/2024 | Date of stock disposal transaction |
| 09/03/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.